 | Up a level |
Schäfer, J.; Young, J.; Bernasconi, E.; Ledergerber, B.; Nicca, D.; Calmy, A.; Cavassini, M.; Furrer, H.; Battegay, M.; Bucher, H. C. (2014). Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study. HIV medicine, 16(1), pp. 3-14. Blackwell Science 10.1111/hiv.12165
Kasenda, B.; Schandelmaier, S.; Sun, X.; von Elm, E.; You, J.; Blumle, A.; Tomonaga, Y.; Saccilotto, R.; Amstutz, A.; Bengough, T.; Meerpohl, J. J.; Stegert, M.; Olu, K. K.; Tikkinen, K. A. O.; Neumann, I.; Carrasco-Labra, A.; Faulhaber, M.; Mulla, S. M.; Mertz, D.; Akl, E. A.; ... (2014). Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications. BMJ, 349(aug01 1), g4921-g4921. BMJ Publishing Group 10.1136/bmj.g4921
Rotger, M.; Glass, T. R.; Junier, T.; Lundgren, J.; Neaton, J. D.; Poloni, E. S.; van 't Wout, A. B.; Lubomirov, R.; Colombo, S.; Martinez, R.; Rauch, Andri; Gunthard, H. F.; Neuhaus, J.; Wentworth, D.; van Manen, D.; Gras, L. A.; Schuitemaker, H.; Albini, L.; Torti, C.; Jacobson, L. P.; ... (2013). Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons. Clinical infectious diseases, 57(1), pp. 112-121. Oxford University Press 10.1093/cid/cit196
Rudin, C.; Wolbers, M.; Nadal, D.; Rickenbach, M.; Bucher, H. C.; Raio, L. (2010). Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children. Archives of disease in childhood, 36(5), pp. 525-529. London: BMJ Publishing Group 10.1136/adc.2009.169375
